
The Translational Research Group investigates the molecular mechanisms of neurodegenerative diseases and cancer. The Translational Neurodegeneration Laboratory develops early diagnostic and neuroprotection strategies using microglial cell models and blood-based biomarkers. Translational cancer research examines organ-specific metastasis processes in detail using three-dimensional models and omics analyses to identify new antimetastatic targets and drug candidates.